Siddha & Ayurvedic Medicine — Clinical Validation

Type: therapy

Status: Active research

Developer: AYUSH / ICMR / CCRAS

Breakthrough Summary

Growing clinical evidence for traditional formulations. Gymnema sylvestre reduces HbA1c by 0.6-1.0% as adjunct therapy. India's AYUSH ministry funding large-scale RCTs for diabetes management.

Mechanism of Action

Gymnema sylvestre, fenugreek, and bitter gourd formulations as adjunct therapy for glycemic control

Year: 2025-2026